APGE - Apogee Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
53.95 1.83 (3.39%) --- --- --- -0.15 (-0.27%) 2.59 (4.87%) --- -0.15 (-0.27%)

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
-1.13
Diluted EPS:
-1.13
Basic P/E:
-49.3628
Diluted P/E:
-49.3628
RSI(14) 1m:
69.49
VWAP:
55.96
RVol:
1.0596

Events

Period Kind Movement Occurred At

Related News